Literature DB >> 16797164

Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.

K Hashimoto, T Sudo, M Hirano, H Motomura, K Tagawa, S Nashiro, K Uemura, S Yoshimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16797164     DOI： 10.1016/j.schres.2006.03.048

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex.

Authors:  S Yamamura; K Ohoyama; T Hamaguchi; M Nakagawa; D Suzuki; T Matsumoto; E Motomura; H Tanii; T Shiroyama; M Okada
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

2.  Zotepine-induced convulsive seizures in a chronic case of treatment resistant paranoid schizophrenia.

Authors:  Praveen Khairkar; Neha Gupta; Sushil Kumar Varma
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

3.  Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice.

Authors:  Hiroshi Ueno; Shunsuke Suemitsu; Shinji Murakami; Naoya Kitamura; Kenta Wani; Yu Takahashi; Yosuke Matsumoto; Motoi Okamoto; Takeshi Ishihara
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.